Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

A Attar, M Lemann, A Ferguson, M Halphen… - Gut, 1999 - gut.bmj.com
Background Polyethylene glycol (PEG) 3350 is a non-absorbable, non-metabolised osmotic
agent used in lavage solutions for gut cleansing. Aims To compare the efficacy of PEG and …

Comparison of efficacy and safety of two doses of two different polyethylene glycol‐based laxatives in the treatment of constipation

S Chaussade, M Minić - Alimentary pharmacology & …, 2003 - Wiley Online Library
Aim: To compare standard and maximum daily doses of polyethylene glycol 3350 plus
electrolytes (Transipeg) and polyethylene glycol 4000 (Forlax) in a multicentre, double …

Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional …

E Corazziari, D Badiali, G Bazzocchi, G Bassotti… - Gut, 2000 - gut.bmj.com
AIMS To assess the long term therapeutic effectiveness, safety, and tolerability of low daily
doses of isosmotic PEG electrolyte solutions (PMF-100) administered for a six month period …

Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study.

RI Andorsky, F Goldner - American Journal of …, 1990 - search.ebscohost.com
The purpose of this study was to demonstrate that polyethylene glycol electrolyte lavage
solution (PEG-ELS), a colonic lavage solution presently used for gut cleansing in …

Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation

E Corazziari, D Badiali, FI Habib, G Reboa… - Digestive diseases and …, 1996 - Springer
The present multicenter double-blind placebo-controlled trial evaluates the therapeutic
effectiveness of small-volume daily doses of an isosmotic polyethylene glycol (PEG) …

A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation

JA DiPalma, J McGowan, JL Herrera - Official journal of the …, 2007 - journals.lww.com
OBJECTIVES Polyethylene glycol (PEG) 3350 (MiraLAX) is currently approved for the short-
term treatment of occasional constipation. This study was designed to compare the safety …

Systematic review and meta analysis: polyethylene glycol in adults with non‐organic constipation

JD Belsey, M Geraint, TA Dixon - International journal of clinical …, 2010 - Wiley Online Library
It is unclear how polyethylene glycol (PEG) laxatives compare with other classes of laxative
in terms of efficacy. To assess efficacy of PEG vs. placebo and active comparators in adults …

A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative

JA DiPalma, PH DeRidder, RC Orlando… - The American journal of …, 2000 - Elsevier
OBJECTIVE: This study was designed to determine the efficacy and safety of a new laxative,
Braintree polyethylene glycol (PEG) laxative (Miralax, Braintree Laboratories, Braintree …

Prospective, randomized, parallel‐group trial to evaluate the effects of lactulose and polyethylene glycol‐4000 on colonic flora in chronic idiopathic constipation

Y Bouhnik, C Neut, L Raskine, C Michel… - Alimentary …, 2004 - Wiley Online Library
Background: Although lactulose and polyethylene glycol are osmotic laxatives widely used
in the treatment of chronic constipation, no study has been conducted to compare their …

Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study

MA Thomson, HR Jenkins, WM Bisset… - Archives of disease in …, 2007 - adc.bmj.com
Objectives: To assess the efficacy and safety of polyethylene glycol 3350 plus electrolytes
(PEG+ E) for the treatment of chronic constipation in children. Design: Randomised, double …